Jan Fehr
- Virology top 1%
- HIV Research and Treatment 21
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment 37
- HIV/AIDS Research and Interventions 35
- Tuberculosis Research and Epidemiology 17
- SARS-CoV-2 and COVID-19 Research 15
- Immunology and Allergy top 1%
- Hepatology top 2%
- Hepatitis C virus research 23
- Parasitology top 2%
-
- Pneumocystis jirovecii pneumonia detection and treatment 16
-
- Travel-related health issues 13
- Co-authors
- HS JacobRené MoserA P DalmassoP R CraddockB SchleiffenbaumClemens A. DahindenPeter GroscurthP.L.B. Bruijnzeel
- Journals
- HIV Medicine (12 papers)Travel Medicine and Infectious Disease (10 papers)BMC Infectious Diseases (9 papers)
- Partner nations
- SwitzerlandUnited StatesUganda
In The Last Decade
Jan Fehr
182 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Virology 581
- Infectious Diseases 2.0k
- Immunology and Allergy 443
- Hepatology 486
- Parasitology 303
Countries citing papers authored by Jan Fehr
This map shows the geographic impact of Jan Fehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Fehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Fehr more than expected).
Fields of papers citing papers by Jan Fehr
This network shows the impact of papers produced by Jan Fehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Fehr. The network helps show where Jan Fehr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Fehr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 53 | |
| 15 | 2020 | 23 | |
| 16 | 2019 | 51 | |
| 17 | 2019 | 41 | |
| 18 | 2018 | 13 | |
| 19 | [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland]. | 2000 | 2 |
| 20 | [Disparity in the circulating and marginal granulocyte pool: evidence from studies on the alkaline granulocyte phosphatase]. | 1978 | 1 |
About Jan Fehr
Jan Fehr is a scholar working on Infectious Diseases, Virology and Hepatology, having authored 195 papers that have together received 5.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (37 papers), HIV/AIDS Research and Interventions (35 papers), Hepatitis C virus research (23 papers), HIV Research and Treatment (21 papers), Tuberculosis Research and Epidemiology (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (16 papers), SARS-CoV-2 and COVID-19 Research (15 papers) and Travel-related health issues (13 papers). The work is most often cited by research in Virology (581 citations), Infectious Diseases (2.0k citations) and Immunology and Allergy (443 citations). Jan Fehr has collaborated with scholars based in Switzerland, United States and Uganda. Frequent co-authors include HS Jacob, René Moser, A P Dalmasso, P R Craddock, B Schleiffenbaum, Clemens A. Dahinden, Peter Groscurth, P.L.B. Bruijnzeel, Milo A. Puhan and Tala Ballouz. Their work appears in journals such as HIV Medicine, Travel Medicine and Infectious Disease, BMC Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.